Our response to the NICE Early Value Assessment (NICE EVA)

NICE EVA initial draft guidance: Artificial intelligence (AI) technologies for assessing and triaging skin lesions within the urgent suspected skin cancer pathway

We have seen the draft guidance and continue to work with NICE as it is finalised. At this stage, “NICE has received resolution requests. Therefore guidance publication will be suspended while the requests are reviewed via the resolution process”.

While we work through the resolution process, NHSE has been very clear to us that they want us to continue to deploy our technology to support dermatology departments across England.

Finally, we note that this evaluation doesn’t include the most recent independent evaluation referenced on the NHSE blog here.

Subscribe to our news updates

We won't spam
you, we promise.